Delivery of antibiotics to the respiratory tract: an update.
about
The role of disposable inhalers in pulmonary drug delivery.Solid lipid budesonide microparticles for controlled release inhalation therapy.Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy.Study of nebulization delivery of aerosolized fluorescent microspheres to the avian respiratory tract.The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.Levofloxacin-proliposomes: opportunities for use in lung tuberculosis.Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management.Inhaled antibiotics for gram-negative respiratory infections.Liposomes as drug delivery systems for the treatment of TB.Liposomal antibiotics for the treatment of infectious diseases.Inhaled antibiotics to treat lung infection.How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder?Epithelial profiling of antibiotic controlled release respiratory formulations.Composition influence on pulmonary delivery of rifampicin liposomesA review on recent technologies for the manufacture of pulmonary drugs.New opportunities for managing acute and chronic lung infections.Phospholipids in pulmonary drug delivery
P2860
Q30368417-39A6BC30-DEEF-435A-9E8C-5E9CB1C67F64Q33515824-C8E4F89C-A5C2-4E88-80DB-5E47F5C26780Q34114591-F97E8FFE-C935-400B-B852-857C73FB7188Q34362474-0AD2A007-4434-44CE-92EA-25740D0C700FQ35861377-0927A02E-9D03-45DF-B453-00485D1CBC5FQ37327834-59E426CC-8386-43A8-B866-0E923A9F3001Q37469403-C1CEA879-1478-479D-AA55-6AC97FD5D9A6Q37880077-F2F01732-C2C3-448B-BAC7-529A4035BB48Q37937558-B2E64662-C2C7-4861-AE9A-DEF4B88EE6F5Q37949386-8B8B530E-5B4D-480A-B568-FCF0BDA88B40Q38124144-CB4A6595-9270-4E06-8A27-2723A4D58D6BQ38162996-131E3130-6D1E-4AA0-8577-119ADD83CCDBQ38859067-176FCC08-CFD1-4BA9-8F93-D1E54D77F4C6Q39536127-161E8506-04E1-44E0-B414-621B54320FF5Q42087785-41C0DCA7-787A-4008-BDB4-057D0CB02ACCQ47272028-7F641B8B-D95D-44CF-B918-0B4E224F839BQ47734944-E7A4D5CF-B941-4FC4-85D5-88CC7060900DQ59089495-83EE1B81-676B-4288-8D7A-6BDD80F783C7
P2860
Delivery of antibiotics to the respiratory tract: an update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delivery of antibiotics to the respiratory tract: an update.
@en
Delivery of antibiotics to the respiratory tract: an update.
@nl
type
label
Delivery of antibiotics to the respiratory tract: an update.
@en
Delivery of antibiotics to the respiratory tract: an update.
@nl
prefLabel
Delivery of antibiotics to the respiratory tract: an update.
@en
Delivery of antibiotics to the respiratory tract: an update.
@nl
P2860
P1476
Delivery of antibiotics to the respiratory tract: an update.
@en
P2093
Paul M Young
P2860
P304
P356
10.1517/17425240903110710
P407
P577
2009-09-01T00:00:00Z